TreeWAS – Variant ID: rs12204683

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D86.0 Sarcoidosis of lung	0.031	0.969	0.000
D86 Sarcoidosis	0.024	0.976	0.000
D86.1 Sarcoidosis of lymph nodes	0.023	0.977	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.022	0.978	0.000
D86.9 Sarcoidosis, unspecified	0.020	0.980	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.018	0.982	0.000
D86.8 Sarcoidosis of other and combined sites	0.018	0.982	0.000
T39.0 Salicylates	0.017	0.983	0.000
I38 Endocarditis, valve unspecified	0.017	0.983	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.016	0.984	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.015	0.985	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.015	0.985	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.015	0.985	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
D86.3 Sarcoidosis of skin	0.014	0.986	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.014	0.986	0.000
T45.0 Antiallergic and antiemetic drugs	0.014	0.986	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.013	0.986	0.000
M79.80 Other specified soft tissue disorders (Multiple sites)	0.013	0.987	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.013	0.987	0.000
T43.2 Other and unspecified antidepressants	0.013	0.987	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.013	0.987	0.000
K41 Femoral hernia	0.012	0.988	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.012	0.988	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.012	0.988	0.000
M79.8 Other specified soft tissue disorders	0.012	0.988	0.000
T40.2 Other opioids	0.012	0.988	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.988	0.000
T45.2 Vitamins, not elsewhere classified	0.011	0.988	0.000
T43.9 Psychotropic drug, unspecified	0.011	0.989	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.989	0.000
T45.5 Anticoagulants	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.011	0.989	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.011	0.989	0.000
T45.8 Other primarily systemic and haematological agents	0.011	0.989	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.011	0.989	0.000
T45.6 Fibrinolysis-affecting drugs	0.011	0.989	0.000
T45.4 Iron and its compounds	0.011	0.989	0.000
T45.3 Enzymes, not elsewhere classified	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T39.4 Antirheumatics, not elsewhere classified	0.011	0.989	0.000
T39.2 Pyrazolone derivatives	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.010	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.010	0.990	0.000
T44.0 Anticholinesterase agents	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.010	0.990	0.000
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.010	0.990	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.010	0.990	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.010	0.990	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.990	0.000
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.010	0.990	0.000
D80-D89 Certain disorders involving the immune mechanism	0.010	0.990	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.010	0.990	0.000
T40.6 Other and unspecified narcotics	0.009	0.990	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
M79.88 Other specified soft tissue disorders (Other)	0.009	0.990	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.991	0.000
T40.8 Lysergide [LSD]	0.009	0.991	0.000
T40.7 Cannabis (derivatives)	0.009	0.991	0.000
T40.5 Cocaine	0.009	0.991	0.000
T40.3 Methadone	0.009	0.991	0.000
T40.1 Heroin	0.009	0.991	0.000
T40.0 Opium	0.009	0.991	0.000
N04.9 Unspecified	0.009	0.991	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.009	0.991	0.000
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.009	0.991	0.000
K41.1 Bilateral femoral hernia, with gangrene	0.009	0.991	0.000
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.009	0.991	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.009	0.991	0.000
T37.5 Antiviral drugs	0.009	0.991	0.000
T37.4 Anthelminthics	0.009	0.991	0.000
T37.3 Other antiprotozoal drugs	0.009	0.991	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.009	0.991	0.000
T37.1 Antimycobacterial drugs	0.009	0.991	0.000
T37.0 Sulphonamides	0.009	0.991	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.009	0.991	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.009	0.991	0.000
T38.9 Other and unspecified hormone antagonists	0.008	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.991	0.000
T38.7 Androgens and anabolic congeners	0.008	0.991	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.991	0.000
T38.5 Other oestrogens and progestogens	0.008	0.991	0.000
T38.4 Oral contraceptives	0.008	0.991	0.000
T38.2 Antithyroid drugs	0.008	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.008	0.991	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.008	0.991	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.008	0.991	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
D80 Immunodeficiency with predominantly antibody defects	0.008	0.992	0.000
M79.89 Other specified soft tissue disorders (Site unspecified)	0.008	0.992	0.000
T40.4 Other synthetic narcotics	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
G60.0 Hereditary motor and sensory neuropathy	0.008	0.992	0.000
G70.0 Myasthenia gravis	0.000	0.992	0.008
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.3 Macrolides	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
D83 Common variable immunodeficiency	0.008	0.992	0.000
T38.1 Thyroid hormones and substitutes	0.008	0.992	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.993	0.007
T36.0 Penicillins	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.007	0.993	0.000
D82 Immunodeficiency associated with other major defects	0.007	0.993	0.000
D81 Combined immunodeficiencies	0.007	0.993	0.000
J94.8 Other specified pleural conditions	0.000	0.993	0.007
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.007	0.993	0.000
I61 Intracerebral haemorrhage	0.000	0.993	0.007
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.993	0.007
T46.3 Coronary vasodilators, not elsewhere classified	0.007	0.993	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
T47.7 Emetics	0.007	0.993	0.000
T47.6 Antidiarrhoeal drugs	0.007	0.993	0.000
T47.5 Digestants	0.007	0.993	0.000
T47.3 Saline and osmotic laxatives	0.007	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
T47.4 Other laxatives	0.007	0.993	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.007	0.993	0.000
G70 Myasthenia gravis and other myoneural disorders	0.000	0.993	0.007
D83.9 Common variable immunodeficiency, unspecified	0.006	0.993	0.000
D84 Other immunodeficiencies	0.006	0.993	0.000
R49.0 Dysphonia	0.006	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
M79.82 Other specified soft tissue disorders (Upper arm)	0.006	0.994	0.000
G70.9 Myoneural disorder, unspecified	0.000	0.994	0.006
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.006	0.994	0.000
T46.7 Peripheral vasodilators	0.006	0.994	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.994	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
M23.49 Loose body in knee-Unspec lig/men	0.006	0.994	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.006	0.994	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.006	0.994	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.006	0.994	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.006	0.994	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.006	0.994	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.994	0.006
T50.8 Diagnostic agents	0.006	0.994	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.006	0.994	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.994	0.006
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.006	0.994	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.006	0.994	0.000
K56.4 Other impaction of intestine	0.000	0.994	0.006
T46.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
D83.8 Other common variable immunodeficiencies	0.006	0.994	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.006	0.994	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.006	0.994	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.006	0.994	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.994	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.994	0.006
F43.2 Adjustment disorders	0.006	0.994	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.994	0.006
D81.9 Combined immunodeficiency, unspecified	0.005	0.994	0.000
D81.8 Other combined immunodeficiencies	0.005	0.994	0.000
D81.7 Major histocompatibility complex class II deficiency	0.005	0.994	0.000
D81.6 Major histocompatibility complex class I deficiency	0.005	0.994	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.005	0.994	0.000
D81.4 Nezelof's syndrome	0.005	0.994	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.005	0.994	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.005	0.994	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.005	0.994	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.005	0.994	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.005	0.994	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.005	0.994	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.005	0.994	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.005	0.994	0.000
D82.2 Immunodeficiency with short-limbed stature	0.005	0.994	0.000
D82.1 Di George's syndrome	0.005	0.994	0.000
D82.0 Wiskott-Aldrich syndrome	0.005	0.994	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.005	0.995	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.005	0.995	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.995	0.005
G70.8 Other specified myoneural disorders	0.000	0.995	0.005
G70.2 Congenital and developmental myasthenia	0.000	0.995	0.005
G70.1 Toxic myoneural disorders	0.000	0.995	0.005
D84.1 Defects in the complement system	0.005	0.995	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.005	0.995	0.000
D84.8 Other specified immunodeficiencies	0.005	0.995	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.995	0.005
T42.1 Iminostilbenes	0.005	0.995	0.000
N04 Nephrotic syndrome	0.005	0.995	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.004	0.995	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.005	0.995	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.995	0.000
T42.3 Barbiturates	0.004	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.995	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.001
K61.3 Ischiorectal abscess	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
I44.7 Left bundle-branch block, unspecified	0.004	0.996	0.000
T93.0 Sequelae of open wound of lower limb	0.004	0.996	0.000
D84.9 Immunodeficiency, unspecified	0.004	0.996	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.004	0.996	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.004	0.996	0.000
G60 Hereditary and idiopathic neuropathy	0.004	0.996	0.000
I44.1 Atrioventricular block, second degree	0.004	0.996	0.000
N04.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
D89.3 Immune reconstitution syndrome	0.004	0.996	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.004	0.996	0.000
R49 Voice disturbances	0.004	0.996	0.000
G70-G73 Diseases of myoneural junction and muscle	0.000	0.996	0.004
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.004	0.996	0.000
D89.1 Cryoglobulinaemia	0.004	0.996	0.000
N04.8 Other	0.004	0.996	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N04.6 Dense deposit disease	0.004	0.996	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N04.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N04.0 Minor glomerular abnormality	0.004	0.996	0.000
T93 Sequelae of injuries of lower limb	0.004	0.996	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.004	0.996	0.000
I44 Atrioventricular and left bundle-branch block	0.004	0.996	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.003	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.996	0.000
F60 Specific personality disorders	0.003	0.997	0.000
G24.5 Blepharospasm	0.003	0.997	0.000
F60.3 Emotionally unstable personality disorder	0.003	0.997	0.000
G71 Primary disorders of muscles	0.000	0.997	0.003
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.003	0.997	0.000
R49.1 Aphonia	0.003	0.997	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.003	0.997	0.000
I44.6 Other and unspecified fascicular block	0.003	0.997	0.000
I44.0 Atrioventricular block, first degree	0.003	0.997	0.000
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
G60.3 Idiopathic progressive neuropathy	0.003	0.997	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.003	0.997	0.000
G60.1 Refsum's disease	0.003	0.997	0.000
G72 Other myopathies	0.000	0.997	0.003
F60.6 Anxious [avoidant] personality disorder	0.003	0.997	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.003	0.997	0.000
G71.3 Mitochondrial myopathy, not elsewhere classified	0.000	0.997	0.003
R49.8 Other and unspecified voice disturbances	0.003	0.997	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.003	0.997	0.000
K04.5 Chronic apical periodontitis	0.000	0.997	0.003
J94 Other pleural conditions	0.000	0.997	0.003
I44.2 Atrioventricular block, complete	0.003	0.997	0.000
R49.2 Hypernasality and hyponasality	0.003	0.997	0.000
Z91.5 Personal history of self-harm	0.003	0.997	0.000
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.000	0.997	0.003
F60.0 Paranoid personality disorder	0.003	0.997	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.997	0.003
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.003	0.997	0.000
F60.7 Dependent personality disorder	0.003	0.997	0.000
F60.5 Anankastic personality disorder	0.003	0.997	0.000
F43.0 Acute stress reaction	0.003	0.997	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.003	0.997	0.000
G72.9 Myopathy, unspecified	0.000	0.997	0.003
I44.5 Left posterior fascicular block	0.003	0.997	0.000
G71.1 Myotonic disorders	0.000	0.997	0.003
F43.9 Reaction to severe stress, unspecified	0.003	0.997	0.000
J94.2 Haemothorax	0.000	0.997	0.003
I44.4 Left anterior fascicular block	0.003	0.997	0.000
F23 Acute and transient psychotic disorders	0.003	0.997	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.997	0.003
Q54.9 Hypospadias, unspecified	0.000	0.997	0.003
F60.8 Other specific personality disorders	0.003	0.997	0.000
F60.4 Histrionic personality disorder	0.003	0.997	0.000
F60.2 Dissocial personality disorder	0.003	0.997	0.000
F60.1 Schizoid personality disorder	0.003	0.997	0.000
G71.9 Primary disorder of muscle, unspecified	0.000	0.997	0.003
G71.8 Other primary disorders of muscles	0.000	0.997	0.003
G71.2 Congenital myopathies	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.003	0.997	0.000
F43.8 Other reactions to severe stress	0.003	0.997	0.000
G72.4 Inflammatory myopathy, not elsewhere classified	0.000	0.997	0.003
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.003	0.997	0.000
G72.8 Other specified myopathies	0.000	0.997	0.003
G72.3 Periodic paralysis	0.000	0.997	0.002
G72.2 Myopathy due to other toxic agents	0.000	0.997	0.002
G72.1 Alcoholic myopathy	0.000	0.997	0.002
N48.0 Leukoplakia of penis	0.000	0.997	0.003
T93.9 Sequelae of unspecified injury of lower limb	0.003	0.997	0.000
H52.0 Hypermetropia	0.000	0.997	0.003
J94.9 Pleural condition, unspecified	0.000	0.997	0.002
J94.0 Chylous effusion	0.000	0.997	0.002
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.997	0.000
G73.7 Myopathy other diseases classified elsewhere	0.000	0.998	0.002
G73.6 Myopathy in metabolic diseases	0.000	0.998	0.002
G73.5 Myopathy in endocrine diseases	0.000	0.998	0.002
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
G73.3 Myasthenic syndromes in other diseases classified elsewhere	0.000	0.998	0.002
G73.2 Other myasthenic syndromes in neoplastic disease	0.000	0.998	0.002
G73.1 Eaton-Lambert syndrome	0.000	0.998	0.002
G73.0 Myasthenic syndromes in endocrine diseases	0.000	0.998	0.002
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.002	0.998	0.000
G24 Dystonia	0.002	0.998	0.000
G72.0 Drug-induced myopathy	0.000	0.998	0.002
M23.4 Loose body in knee	0.002	0.998	0.000
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
F60-F69 Disorders of adult personality and behaviour	0.002	0.998	0.000
G71.0 Muscular dystrophy	0.000	0.998	0.002
D37.7 Other digestive organs	0.000	0.998	0.002
B35.1 Tinea unguium	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
F23.8 Other acute and transient psychotic disorders	0.002	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.002	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.002	0.998	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.998	0.000
G24.9 Dystonia, unspecified	0.002	0.998	0.000
G24.3 Spasmodic torticollis	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.000	0.998	0.002
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.998	0.002
R25.2 Cramp and spasm	0.002	0.998	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.002	0.998	0.000
J94.1 Fibrothorax	0.000	0.998	0.002
M10.99 Gout, unspecified (Site unspecified)	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
J30.1 Allergic rhinitis due to pollen	0.000	0.998	0.002
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
F61 Mixed and other personality disorders	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.002	0.998	0.000
W22.9 Unspecified place	0.002	0.998	0.000
B44.9 Aspergillosis, unspecified	0.000	0.998	0.002
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.002	0.998	0.000
F20 Schizophrenia	0.002	0.998	0.000
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.002	0.998	0.000
G24.4 Idiopathic orofacial dystonia	0.002	0.998	0.000
G24.2 Idiopathic nonfamilial dystonia	0.002	0.998	0.000
G24.1 Idiopathic familial dystonia	0.002	0.998	0.000
G24.0 Drug-induced dystonia	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.002
F99 Mental disorder, not otherwise specified	0.002	0.998	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
M23.47 Loose body in knee-Capsular lig	0.002	0.998	0.000
M23.45 Loose body in knee-Pst hrn lat men	0.002	0.998	0.000
M23.44 Loose body in knee-Lat lig/ant men	0.002	0.998	0.000
M23.42 Loose body in knee-Pst lig/hrn men	0.002	0.998	0.000
M23.41 Loose body in knee-Ant lig/hrn men	0.002	0.998	0.000
M23.40 Loose body in knee-Mult sites	0.002	0.998	0.000
B35 Dermatophytosis	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
G24.8 Other dystonia	0.002	0.998	0.000
F68 Other disorders of adult personality and behaviour	0.002	0.998	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.002	0.998	0.000
F65 Disorders of sexual preference	0.002	0.998	0.000
F63 Habit and impulse disorders	0.002	0.998	0.000
X61.4 Street and highway	0.002	0.998	0.000
F64 Gender identity disorders	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
F62.9 Enduring personality change, unspecified	0.002	0.998	0.000
B44 Aspergillosis	0.000	0.998	0.002
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
W17.4 Street and highway	0.000	0.998	0.002
F22 Persistent delusional disorders	0.002	0.998	0.000
M23.43 Loose body in knee-Med lig/oth men	0.002	0.998	0.000
B35.6 Tinea cruris	0.000	0.998	0.002
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
J30.3 Other allergic rhinitis	0.000	0.998	0.002
B44.1 Other pulmonary aspergillosis	0.000	0.998	0.002
F43.1 Posttraumatic stress disorder	0.002	0.998	0.000
Z96.9 Presence of functional implant, unspecified	0.002	0.998	0.000
B49 Unspecified mycosis	0.000	0.998	0.002
S89.9 Unspecified injury of lower leg	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
F28 Other nonorganic psychotic disorders	0.002	0.998	0.000
F24 Induced delusional disorder	0.002	0.998	0.000
F21 Schizotypal disorder	0.002	0.998	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.998	0.002
F20.5 Residual schizophrenia	0.002	0.998	0.000
F69 Unspecified disorder of adult personality and behaviour	0.002	0.998	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.998	0.002
F62.8 Other enduring personality changes	0.002	0.998	0.000
F62.1 Enduring personality change after psychiatric illness	0.002	0.998	0.000
F62.0 Enduring personality change after catastrophic experience	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
X78.0 Home	0.002	0.998	0.000
Q54 Hypospadias	0.000	0.998	0.002
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
F20.8 Other schizophrenia	0.002	0.998	0.000
F20.6 Simple schizophrenia	0.002	0.998	0.000
F20.4 Postschizophrenic depression	0.002	0.998	0.000
F20.3 Undifferentiated schizophrenia	0.002	0.998	0.000
F20.2 Catatonic schizophrenia	0.002	0.998	0.000
F20.1 Hebephrenic schizophrenia	0.002	0.998	0.000
Z81.8 Family history of other mental and behavioural disorders	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
M23.46 Loose body in knee-O/unsp lat men	0.002	0.998	0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.002	0.998	0.000
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.002	0.998	0.000
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.002	0.998	0.000
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.002	0.998	0.000
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.002	0.998	0.000
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.002	0.998	0.000
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.002	0.998	0.000
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.002	0.998	0.000
X69.9 Unspecified place	0.002	0.998	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.002	0.998	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.000	0.998	0.002
S82.30 Fracture of lower end of tibia (closed)	0.000	0.998	0.002
L05.0 Pilonidal cyst with abscess	0.002	0.998	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.998	0.002
B35.9 Dermatophytosis, unspecified	0.000	0.998	0.002
B35.8 Other dermatophytoses	0.000	0.998	0.002
B35.5 Tinea imbricata	0.000	0.998	0.002
B35.4 Tinea corporis	0.000	0.998	0.002
B35.2 Tinea manuum	0.000	0.998	0.002
B35.0 Tinea barbae and tinea capitis	0.000	0.998	0.002
F42.9 Obsessive-compulsive disorder, unspecified	0.002	0.998	0.000
F63.9 Habit and impulse disorder, unspecified	0.001	0.998	0.000
F63.8 Other habit and impulse disorders	0.001	0.998	0.000
F63.3 Trichotillomania	0.001	0.998	0.000
F63.2 Pathological stealing [kleptomania]	0.001	0.998	0.000
F63.1 Pathological fire-setting [pyromania]	0.001	0.998	0.000
F63.0 Pathological gambling	0.001	0.998	0.000
F65.9 Disorder of sexual preference, unspecified	0.001	0.998	0.000
F65.8 Other disorders of sexual preference	0.001	0.998	0.000
F65.6 Multiple disorders of sexual preference	0.001	0.998	0.000
F65.5 Sadomasochism	0.001	0.998	0.000
F65.4 Paedophilia	0.001	0.998	0.000
F65.3 Voyeurism	0.001	0.998	0.000
F65.2 Exhibitionism	0.001	0.998	0.000
F65.1 Fetishistic transvestism	0.001	0.998	0.000
F65.0 Fetishism	0.001	0.998	0.000
F66.9 Psychosexual development disorder, unspecified	0.001	0.998	0.000
F66.8 Other psychosexual development disorders	0.001	0.998	0.000
F66.2 Sexual relationship disorder	0.001	0.998	0.000
F66.1 Egodystonic sexual orientation	0.001	0.998	0.000
F66.0 Sexual maturation disorder	0.001	0.998	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.001	0.998	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.001	0.998	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.001	0.998	0.000
Q54.0 Hypospadias, balanic	0.000	0.998	0.002
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
F64.9 Gender identity disorder, unspecified	0.001	0.998	0.000
F64.8 Other gender identity disorders	0.001	0.998	0.000
F64.2 Gender identity disorder of childhood	0.001	0.998	0.000
F64.1 Dual-role transvestism	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations